We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Voluntarily Files for Chapter 11 Restructuring Strategic Alternatives Process Continues with Interest from Parties Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the “Company”), a...
-- Preliminary randomized Phase 2 data suggest GRANITE (personalized neoantigen vaccine) could drive meaningful clinical benefit in front-line metastatic microsatellite-stable colorectal cancer...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
4 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
12 | 0 | 0 | 0.0322 | 0.0322 | 0.0322 | 0 | 0 | CS |
26 | -0.4878 | -93.8076923077 | 0.52 | 0.66 | 0.031 | 8547790 | 0.08942374 | CS |
52 | -2.2578 | -98.5938864629 | 2.29 | 3.1 | 0.031 | 5359179 | 0.32476884 | CS |
156 | -5.1078 | -99.373540856 | 5.14 | 6.1 | 0.031 | 2613666 | 1.08995331 | CS |
260 | -8.5778 | -99.6260162602 | 8.61 | 34.67 | 0.031 | 1984954 | 3.63587741 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions